It will identify up to 25 best health tech solutions from startups/ SMEs and provide pilot testbeds in collaboration with State governments and industry to help their validation and scale-up for adoption.
The partnership will allow Dr Reddy’s to identify and use some of BIRAC’s clinical trial centres for the vaccine, which are funded under the National Biopharma Mission (NBM), implemented by Project Management Unit-NBM at BIRAC.
The shortlisted proposals includes10 vaccines candidates, 34 diagnostics products or scale-up facilities, 10 therapeutics options, two proposals on drug repurposing and 14 projects which are categorised as preventive interventions.
In the wake of the Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC) inviting applications on COVID-19 Research Consortium, around 500 applications were received from academia and industry.